Back to top

NON-EXCLUSIVE PATENT LICENSE

License Agreement

NON-EXCLUSIVE PATENT LICENSE | Document Parties: ALMA LASERS LTD. | Palomar Medical Technologies, Inc You are currently viewing:
This License Agreement involves

ALMA LASERS LTD. | Palomar Medical Technologies, Inc

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: NON-EXCLUSIVE PATENT LICENSE
Governing Law: Massachusetts     Date: 12/31/2007
Law Firm: Goodwin Procter    

NON-EXCLUSIVE PATENT LICENSE, Parties: alma lasers ltd. , palomar medical technologies  inc
50 of the Top 250 law firms use our Products every day
 
EXHIBIT 10.24
 
NON-EXCLUSIVE PATENT LICENSE
     THIS NON-EXCLUSIVE PATENT LICENSE (this “ Agreement ”) is made and entered into as of the 29th day of March, 2007 (the “Effective Date ”), by and among Palomar Medical Technologies, Inc., a Delaware corporation, with offices at 82 Cambridge Street, Burlington, MA 01803 (“Palomar”), Alma Lasers, Inc., a Delaware corporation, with offices at 485 Half Day Road #100, Buffalo Grove, IL 60089, and Alma Lasers, Ltd., an Israeli company, with offices at 7 Halamish Street, Caesarea Industrial Park, Caesarea, Israel 38900 (Alma Lasers, Inc. and Alma Lasers, Ltd., collectively, “ Alma ”) (Palomar on the one hand, and Alma together with all Alma Affiliates (as defined below) on the other hand, each a “ Party ”, and together, the “ Parties ”).
WITNESSETH :
     WHEREAS, Palomar and MGH (as defined below), on the one hand, and Alma Lasers, Inc., on the other hand, are parties to a certain patent-related Lawsuit (as defined in the Settlement Agreement (as defined below));
     WHEREAS, Palomar and MGH, on the one hand, and Alma Lasers, Inc., on the other hand, have agreed to enter into that certain Settlement Agreement, to be executed contemporaneously with this Agreement (the “ Settlement Agreement ”), pursuant to which Palomar and MGH, on the one hand, and Alma Lasers, Inc., on the other hand, will settle the patent infringement claims in the Lawsuit among other things;
     WHEREAS, Palomar has a license from MGH under the Anderson Patents (both as defined below) relating to the use of light to remove hair; and
     WHEREAS, Alma and Alma Affiliates desire to obtain, and Palomar is willing to grant, a non-exclusive, royalty-bearing sublicense under the Anderson Patents to develop and commercialize products developed by Alma and Alma Affiliates under the terms of the Settlement Agreement and the following terms and conditions.
     NOW THEREFORE, the Parties hereby agree as follows:
1. Definitions . The following terms (and their correlatives), in addition to terms defined on first use herein, shall have the meanings set forth below:
     1.1. Affiliates.
          (a) “Alma Affiliate” shall mean any person or entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with Alma (i) as of the Effective Date or (ii) after the Effective Date provided such person or entity is not an Excluded Third Party at the time such person or entity first meets the foregoing control requirements (unless Palomar provides its written consent in its sole discretion), in each case of clauses (i) and (ii), only for so long as such person or entity satisfies the foregoing control requirements. For clarity, any Third Party that does not become an “Alma Affiliate” hereunder because of the reference to “Excluded Third Party” in clause (ii) above shall continue to be treated as a “Third Party” for all purposes hereunder.

 


 
Non-Exclusive Patent License
          (b) “ Palomar Affiliate ” shall mean any person or entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with Palomar (i) as of the Effective Date or (ii) after the Effective Date, in each case of clauses (i) and (ii), only for so long as such person or entity satisfies the foregoing requirements.
          (c) “ Affiliates ” shall mean, with respect to any Third Party, any person or entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with such Third Party, in each case only for so long as such person or entity satisfies the foregoing requirement.
     For purposes of this Section 1.1, “control” and, with correlative meanings, the terms “controlled by” and “under common control with” shall mean (i) the possession, directly or indirectly, of the power to direct the management or policies of an entity, whether through the ownership of voting securities, by contract relating to voting rights or corporate governance, or otherwise, or (ii) the ownership, directly or indirectly, of at least fifty percent (50%) of the voting securities or other ownership interest of an entity (or, with respect to a limited partnership or other similar entity, its general partner or controlling entity); provided, that if local law restricts foreign ownership, “control” shall be deemed established by direct or indirect ownership of the maximum ownership percentage that may, under such local law, be owned by foreign interests.
     1.2. “ Alma Modules ” shall mean Alma Hair Modules and Alma Other Modules, each as defined below:
          (a) “Alma Hair Module ” shall mean any energy source module, Sold by Alma or Alma Affiliates, that is marketed as being capable of using or uses or is incorporated into a product or system that uses optical radiation to remove hair. For clarity and without limitation, if in addition to using optical radiation to remove hair, an Alma Hair Module may be used for the treatment of skin (including treatment of vascular and pigmented lesions, acne, fat, cellulite, wrinkles, scars and tattoos, skin tightening, and for other dermatological applications), or other treatment or cosmetic purpose(s), it shall in all events remain an “Alma Hair Module” hereunder.
          (b) “ Alma Other Module ” shall mean any energy source module, Sold by Alma or Alma Affiliates, that is marketed as being capable of using or uses or is incorporated into a product or system that uses optical radiation for the treatment of skin (including treatment of vascular and pigmented lesions, acne, fat, cellulite, wrinkles, scars and tattoos, skin tightening, and for other dermatological applications) or other treatment or cosmetic purposes, other than hair removal; in all events, other than an Alma Hair Module.
     1.3. “ Alma Products ” shall mean Alma Hair Products and Alma Combination Products, each as defined below. “ Alma Other Product ” shall mean any product, system, component or accessory, Sold by Alma or Alma Affiliates, that (i) is not an Alma Product, and (ii) that is marketed as being capable of using or uses or is incorporated into a product or system that uses one or more Alma Other Modules. As of the Effective Date, there are no “Alma Other Products” for purposes of this Agreement.

2


 
Non-Exclusive Patent License
          (a) “ Alma Combination Product ” shall mean any product, system, component or accessory, Sold by Alma or Alma Affiliates, (i) that as of the date of its Sale, is marketed as being capable of using both at least one Alma Other Module and at least one Alma Hair Module, and (ii) the manufacture, use, sale, offering for sale, or importation of which with an Alma Hair Module, absent the sublicense granted by Palomar herein, would infringe a Valid Claim of the Anderson Patents. For clarity and without limitation, Exhibit A lists Alma Combination Products in existence up to the Effective Date and sets forth examples of when an Alma Other Product or an Alma Hair Product shall become an “Alma Combination Product” hereunder (and an example of a marketing technique which does not change an Alma Hair Product into an “Alma Combination Product” hereunder).
          (b) “ Alma Hair Product ” shall mean any product, system, component or accessory, Sold by Alma or Alma Affiliates, (i) that contains an Alma Hair Module, (ii) the manufacture, use, sale, offering for sale, or importation of which, absent the sublicense granted by Palomar herein, would infringe a Valid Claim of the Anderson Patents, and (iii) that as of its date of Sale, is not marketed for use in combination with an Alma Other Module. For clarity and without limitation, Exhibit B provides additional clarifications and lists items that are Alma Hair Products in existence up to the Effective Date.
     1.4. “Alma Sublicensee ” shall mean any Third Party to which Alma or an Alma Affiliate grants a permitted sublicense pursuant to Section 2.2 under the sublicense grant from Palomar in Section 2.1.
     1.5. “ Anderson Patents ” shall mean (i) the Patents set forth on Exhibit C , and (ii) all other Patents that claim the right of priority to, or enjoy the benefit of an earlier filing date of, in whole or in part, directly or indirectly, one or more of the Patents identified in the immediately preceding clause (i).
     1.6. “ Consumer Field ” shall mean the field in which products or systems are intended for or marketed to consumers for personal use. For the avoidance of doubt, the “Consumer Field” shall exclude products or systems in the Professional Field.
     1.7. “ Excluded Third Party ” shall mean any Third Party and its Affiliates against which:
          (a) any suit or action involving any Anderson Patent has been instituted between Palomar or any Palomar Affiliates and such Third Party or any of its Affiliates; or
          (b) Palomar or any of Palomar Affiliates has an outstanding injunction pertaining to infringement of the Anderson Patents;
provided, however, that an Excluded Third Party to which Palomar grants a non-exclusive sublicense under the Anderson Patents within the Professional Field, which sublicense agreement has materially the same terms as this Agreement, shall no longer be deemed an “Excluded Third Party” hereunder effective upon the effective date of such sublicense grant; provided, further, that in the event of an Acquisition (as defined in Section 2.2(e)), such sublicense granted to such Third Party and the terms of such sublicense agreement (and not this Agreement) shall apply to such Third Party’s product(s) and technology, and improvements and derivatives thereto.

3


 
Non-Exclusive Patent License
     1.8. “ Gillette ” shall mean The Gillette Company, and its successors and permitted assigns of the Gillette Agreement.
     1.9. “ Gillette Agreement ” shall mean that certain “Amended and Restated Development and License Agreement” between Palomar and The Gillette Company entered into as of February 14, 2007 and effective as of February 14, 2003, as such agreement is amended as of the Effective Date, including the Amendment to the “Amended and Restated Development and License Agreement” between Palomar and The Gillette Company entered into as of February 14, 2007 and effective as of February 14, 2003, and as such agreement may be amended or restated thereafter in a manner that is not materially inconsistent with the terms of this Agreement. A copy of the Gillette Agreement, excluding exhibits thereto and redactions of other commercially sensitive information, as amended as of the Effective Date is attached hereto at Appendix A.
     1.10. “ Licensed Products ” shall mean Alma Products (including those Alma Hair Modules that alone amount to an “Alma Product” hereunder), provided in each case that such Alma Product is Sold, marketed, promoted and branded primarily as a product of Alma or one or more of Alma Affiliates. For clarity, Licensed Products may include future energy source modules, products, systems, components or accessories Sold by Alma or Alma Affiliates after the Effective Date, as long as such energy source module, product, system, component and accessory satisfies in full the definitional requirements for a “Licensed Product” (and its subsidiary definitions) hereunder.
     1.11. “ MGH ” shall mean The General Hospital Corporation in Boston, Massachusetts.
     1.12. “ MGH Agreement ” shall mean that certain “License Agreement” between Palomar and MGH dated as of August 18, 1995, as such agreement is amended as of the Effective Date and as such agreement may be amended or restated thereafter in a manner that is not materially inconsistent with the terms of this Agreement. A copy of the MGH Agreement, as redacted, as amended as of the Effective Date is attached hereto at Appendix B.
     1.13. “ Net Sales ” shall mean, subject to the remainder of this Section 1.13, all amounts invoiced by Alma and Alma Affiliates, for the Sale to Third Parties of Licensed Products (collectively, the “Actual Amounts” ), less: (i) allowances and adjustments actually credited to customers for damaged and returned product (which allowances and adjustments may be taken only on a product-by-product basis, that is an allowance or adjustment on one product, for example, Sonata System, shall not be taken against Sales of another type of product, for example, a Soprano System or Harmony System); (ii) promotional, trade, quantity, cash and prompt payment discounts separately identified on the invoice and actually allowed and taken; and (iii) Third Party charges of the following kinds collected by the seller from the buyer and separately identified on the invoice: transportation charges, insurance charges for transportation, sales taxes, excise taxes and customs duties, and governmental charges levied on or measured by the sale; provided that: (1) no deductions shall be made from Actual Amounts for any royalties owed or paid to any person or entity; and (2) Net Sales shall include upgrades or additions to, or partial replacements for, Licensed Products, where upgrades include but are not limited to swapping a new Licensed Product for a buyer’s existing product.

4


 
Non-Exclusive Patent License
     For clarity and without limitation, this definition of Net Sales includes Alma Combination Products which do not include an Alma Hair Module for which no royalties are due Palomar hereunder for their Sale. However, as provided in Section 4.4, subsequent Sales of Alma Hair Modules for use with such Alma Combination Products shall affect royalties owed to Palomar. Thus, it shall be necessary to determine and keep records of the Net Sales attributable to all such Licensed Products. As a consequence, inclusion of a Licensed Product in this definition of Net Sales, by itself, shall not indicate that royalties are necessarily due Palomar hereunder on the Sale of such Licensed Product.
     The following paragraphs provide additional non-limiting examples for calculating Net Sales hereunder:
    Trade-in of a first Alma Product (such as a Sonata System) in connection with the Sale of a second Alma Product (such as a Soprano System) shall be treated as follows: (i) the Net Sales attributed to the Sale of such second Alma Product (a) shall not include any deduction or other reduction for the trade-in given by Alma for such first Alma Product, unless Alma paid royalties to Palomar hereunder upon the Sale of such first Alma Product ( e.g. , there shall be no such deduction or other reduction when such first Alma Product is an Alma Other Product), and (b) shall be calculated as set forth in this definition, and such Sale of such second Alma Product shall be subject to the royalty obligations set forth in Section 4.4, and (ii) the Net Sales attributable to any re-Sale of such first Alma Product shall be calculated as set forth in this definition, and such re-Sale of such first Alma Product shall be subject to the royalty obligations set forth in Section 4.4. For example, without limiting the generality of the foregoing, if a customer purchases from Alma a Sonata System for $60,000 before January 1, 2008, then under Section 4.4, Alma is obligated to pay Palomar a royalty of $5,100 on such Sale of the Sonata System (8.5% of $60,000). If that customer then purchases from Alma a Soprano System for $120,000 and is provided a credit of $20,000 in connection with a trade-in of such Sonata System that such customer previously purchased before January 1, 2008 (thus paying Alma $100,000), then under Section 4.4, Alma is obligated to pay Palomar a royalty of $8,500 on such Sale of the Soprano System (8.5% of $100,000) and no amount shall be due hereunder for the $20,000 credit provided for the Sonata System. If Alma then re-Sells the traded-in Sonata System for $40,000 before January 1, 2008, then under Section 4.4, Alma is obligated to pay Palomar a royalty of $3,400 on such re-Sale of the traded-in Sonata System (8.5% of $40,000).
 
    Installation charges, whether or not separately invoiced or identified on an invoice, shall not be deducted from the Actual Amounts.
 
    Charges for the standard warranty for a Licensed Product, whether or not separately invoiced or identified on an invoice, shall not be deducted from the Actual Amounts. However, charges separately identified on an invoice for an extended warranty (after deducting appropriate charges for the standard warranty) may be deducted from Actual Amounts.

5


 
Non-Exclusive Patent License
    Charges for standard or basic training (often referred to as inservice training or initial training) or any training by Alma or Alma Affiliates (collectively referred to as “ Standard Training ”) for a Licensed Product, whether or not separately invoiced or identified on an invoice, shall not be deducted from the Actual Amounts. However, charges separately identified on an invoice for additional training by a Third Party (after deducting appropriate charges for the Standard Training, if such Third Party is to provide the Standard Training) may be deducted from Actual Amounts.
 
    Excluding physically separate light-based systems which are covered in the following paragraph on Bundled Packages, charges for other products, accessories, parts or items listed on an invoice along with a Licensed Product, with no separate and distinct price set forth for those other products, accessories, parts or items on the invoice in question, shall not be deducted from Actual Amounts.
     If Alma or any Alma Affiliate Sells one or more Licensed Product(s), in combination with other, physically separate light-based systems that are not Licensed Products at a single price (a “ Bundled Package ”), then the Net Sales attributable to such Licensed Product(s), for the purpose of determining Net Sales attributable hereunder, shall be calculated by multiplying the Net Sales of such Bundled Package by the fraction A/(A+B), where A is the average Net Sales price of Licensed Product(s) in the relevant country during the applicable calendar quarter as Sold separately in bona fide arms-length transactions by the selling party ( i.e. , Alma or an Alma Affiliate, who shall be deemed to be a “ Selling Party ”), and B is the total average Net Sales price of all other light-based system(s) in the Bundled Package that are not Licensed Product(s) in the relevant country during the applicable calendar quarter, as Sold separately in bona fide arms-length transactions by such Selling Party. If, in any given country and applicable calendar quarter, the Licensed Product(s) and other light-based system(s) included in a Bundled Package are not all Sold separately in bona fide arms-length transactions in such country by the same Selling Party, Net Sales of a Licensed Product(s) included within the Bundled Package shall be calculated using the formula above, using the average Net Sales price in the United States for the applicable calendar quarter of the Licensed Product(s) and the other light-based system(s), again in bona fide arms-length transactions by a single Selling Party. If no average Net Sales prices of the Licensed Product(s) and the other such light-based system(s) is available for the United States for the applicable calendar quarter from bona fide arms-length transactions by a single Selling Party, the Net Sales of the Licensed Product(s) shall be the aggregate Net Sales of such assemblage of Products without deduction of any kind.
     For clarity, (i) subject to clause (iii) below, transfer of a Licensed Product within Alma or between Alma and Alma Affiliates for subsequent Sale to a Third Party shall not be considered a Sale until a Sale is made to a Third Party and the Net Sales shall be based on the Sale to the Third Party of such Licensed Product by Alma or Alma Affiliates, (ii) a Licensed Product shall be considered “Sold” upon the earlier of shipment of or receipt of payment for such Licensed Product or Alma or any Alma Affiliate recognizing revenue with respect to such sale of Licensed Product in accordance with U.S. generally accepted accounting principles, consistently applied, and all royalty obligations on Net Sales of such Licensed Product shall accrue upon the time of Sale regardless of the time of collection by the selling entity, (iii) sales of Licensed Products by

6


 
Non-Exclusive Patent License
Alma Sublicensees (including sales by distributors and subdistributors) shall not give rise to Net Sales hereunder because those products shall have already been Sold by Alma or Alma Affiliates to such Alma Sublicensees, with the Net Sales arising from such Sale already accounted for under this definition; provided, however, that a Sale or transfer of Licensed Products by Alma or Alma Affiliates to Alma Sublicensees that purchase such Licensed Products for the resale or distribution of such Licensed Products in the United States shall not be considered a Sale hereunder until a Sale is made by such Alma Sublicensee or a Third Party distributor in the United States and the Net Sales shall be based on such Sale of such Licensed Product by such Alma Sublicensee or Third Party distributor in the United States, (iv) “amounts invoiced” as used above shall include the value of any monetary or other consideration to be received by Alma or any Alma Affiliates from a Sale of any Licensed Product, (v) Net Sales shall be deemed to be equal to, for any Licensed Product (a) Sold to any Third Party for less than the seller is then charging in bona fide arms-length transactions for comparable products or (b) donated, transferred or given away free of charge, in each case of clauses (a) and (b), the average Net Sales price of such Licensed Product in bona fide arms-length transactions by such seller, (vi) all Sales to any distributors shall include the fair market value of all cash and other consideration received from such distributor, and (vii) all of the amounts specified in this definition shall be determined from the books and records of Alma and Alma Affiliates maintained in accordance with U.S. generally accepted accounting principles, consistently applied.
     1.14. “ Patents ” shall mean (i) any patents and patent applications and any patents issuing therefrom worldwide, (ii) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates, term extensions (under patent or other law), certificates of invention and the like, of any such patents or patent applications, and (iii) any foreign or international equivalents of any of the foregoing.
     1.15. “ Professional Field ” shall mean the field in which products or systems are intended or marketed for sale to doctors, health care providers, beauty care professionals or other commercial service providers for use on or with patients or customers (and not for resale to any person or entity for personal use).
     1.16. “ Sale ” shall mean, with respect to a Licensed Product, the sale, distribution, lease, use (including training, preceptorships, marketing and promotional uses), cost-per-shot arrangements and any other arrangement in which monetary or other consideration is to be received by Alma or one or more Alma Affiliates for the use of such Licensed Product. For clarity, the donation, transferring or giving away free of charge of any Licensed Product hereunder shall constitute a Sale.
     1.17. “ Third Party ” shall mean any person or entity, other than Palomar, Alma or any Palomar Affiliates or Alma Affiliates.
     1.18. “ Valid Claim ” shall mean either (i) a claim of an issued and unexpired Patent which has not been revoked or held permanently unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted to be invalid or unenforceable through opposition, reissue, re-examination or disclaimer or otherwise, or (ii) a

7


 
Non-Exclusive Patent License
claim of a pending application for a Patent which claim was filed in good faith and has not been abandoned or finally disallowed without the possibility of appeal or refiling of said application.
2. License Grants .
     2.1. Sublicense Grant by Palomar . Subject to the terms and conditions of this Agreement, Palomar hereby grants to Alma and Alma Affiliates a worldwide, royalty-bearing, non-exclusive sublicense, under the Anderson Patents, to make, use, sell, offer for sale and import Licensed Products (provided that those Alma Hair Modules that alone amount to an “Alma Product” hereunder are used exclusively with other Alma Products or Alma Other Products and no other products or systems of Alma, Alma Affiliates or any Third Parties), in each case only for hair removal and only outside of the Consumer Field. It is understood and agreed that (i) the foregoing sublicense grant shall cover only those Licensed Products Sold for which royalties are paid to Palomar hereunder as provided in Section 4 (including with respect to Sales of Licensed Products occurring before the Effective Date for which Alma pays royalties hereunder as specified in Section 4.2), (ii) the foregoing sublicense grant automatically extends, without any further action by Alma or any Alma Affiliates, to each person and entity that is an “Alma Affiliate” as of the Effective Date or becomes an “Alma Affiliate” thereafter, but only for so long as such person or entity remains an “Alma Affiliate” hereunder, and (iii) Palomar shall be in direct privity under this Agreement with any Alma Affiliate as a result of such sublicense grant.
     2.2. Related Licensing Provisions.
          (a) Limited Sublicensing Rights . Alma and Alma Affiliates shall not have any right to grant to any Third Parties any further sublicenses under the sublicense grant set forth in Section 2.1, nor shall any purported sublicenses under such sublicense grants made by Alma or any Alma Affiliates or any of their sublicensees prior to the Effective Date be valid or enforceable, except Alma, and only those Alma Affiliates that are wholly-owned by Alma (directly or indirectly, and taking into account any local law restrictions as noted in Section 1.1) and no other Alma Affiliates, may grant sublicenses only as may be necessary for (i) Third Parties to distribute Licensed Products Sold by Alma or Alma Affiliates and for which royalties are payable to Palomar on Net Sales hereunder, or (ii) the manufacture of Licensed Products by Third Parties for sale only to Alma or Alma Affiliates and for which royalties are payable to Palomar on later Net Sales hereunder of such Licensed Products by Alma or Alma Affiliates, provided that, for each of clauses (i) and (ii), any such Third Parties are not Excluded Third Parties, and further provided that any such sublicense grants shall apply only to activities occurring on or after the actual date such sublicense grant is first memorialized in writing (and not before). Alma Sublicensees shall not have the right to grant any sublicenses under any such sublicense grant by Alma or Alma Affiliates. Alma shall be responsible to Palomar for the performance of any Alma Affiliates and Alma Sublicensees under any provisions of this Agreement for which Alma or any Alma Affiliate is responsible, even if such person or entity is also responsible to Palomar. No purchaser of any Licensed Product shall, by operation of this Agreement, receive any license, sublicense or other rights in, to or under the Anderson Patents that exceeds the scope and terms of the sublicense grant set forth in Section 2.1, notwithstanding the patent exhaustion/first sale doctrine. Apart from the foregoing limited right to grant further sublicenses, Alma and Alma Affiliates shall not have any right to

8


 
Non-Exclusive Patent License
make an Assignment or otherwise Transfer such sublicense grant except pursuant to Section 9.3.
          (b) License Field Limitation . Notwithstanding anything contained herein to the contrary, (i) Alma and Alma Affiliates shall not exercise, (ii) Alma shall not allow any Alma Affiliates or Alma Sublicensees to exercise, and (iii) with respect to any distributor, sublicense or other agreements entered into by Alma or any Alma Affiliates, or purchase orders issued or accepted by Alma or any Alma Affiliates, in each case after the Effective Date, Alma shall expressly prohibit in writing all Alma Affiliates and Alma Sublicensees from exercising, the sublicense grant provided for in Section 2.1 within the Consumer Field. With respect to not allowing certain activities by Alma Sublicensees as set forth in clause (ii) of the 1 st sentence of this Section 2.2(b), the Parties understand and agree that, without limiting Alma and an Alma Affiliate’s obligations under such clause, once Alma or any Alma Affiliate learns of any violation of their obligations not to allow any Alma Sublicensee to conduct those prohibited activities, Alma and Alma Affiliates shall promptly use commercially reasonable efforts to end all such prohibited activities by such Alma Sublicensee within a commercially reasonable time period, and if unable to end all such prohibited activities by such efforts, shall in all events within six (6) months of first learning of any such prohibited activities by such Alma Sublicensee: (x) terminate the sublicense to such Alma Sublicensee; and (y) stop Selling (directly or indirectly through other Alma Sublicensees or otherwise) Licensed Products to such Alma Sublicensee. If Palomar notifies Alma in writing of any Alma Sublicensee conducting any such prohibited activities, Alma shall thereafter confirm in writing to Palomar that Alma has complied with the immediately preceding sentence for such Alma Sublicensee.
          (c) Patent Marking . Alma and Alma Affiliates shall mark all Licensed Products Sold after the Effective Date in accordance with the patent laws, if any, of the jurisdictions in which such Licensed Products are manufactured, used or Sold. Without limitation, Alma and Alma Affiliates shall mark all Licensed Products Sold in the United States after the Effective Date with the applicable U.S. patent numbers of the applicable Anderson Patents.
          (d) Palomar’s Right to Grant Other Sublicenses . Subject to the terms of this Agreement, Palomar retains the right to grant sublicenses and other rights in and to the Anderson Patents as Palomar may deem appropriate in its sole discretion.
          (e) Excluded Third Parties . The Parties intend that no Excluded Third Party, or any of their products or other technology, is to be granted any rights under the Anderson Patents sublicensed by Palomar under Section 2.1, either through the direct sublicense from Palomar to Alma and Alma Affiliates under Section 2.1 or as an Alma Sublicensee. Thus, the Parties have agreed to preclude any Excluded Third Party from becoming an “Alma Affiliate” hereunder as provided in Section 1.1(a), and further have agreed to preclude any Assignment of this Agreement by Alma or any Alma Affiliate to or otherwise involving any Excluded Third Party under Section 9.3. Further, Alma and Alma Affiliates hereby agree that to the extent that any of them acquires any rights or interest in or to any product(s) or other technology from any person or entity while or after such person or entity is an “Excluded Third Party” hereunder, whether by Assignment under Section 9.3, asset purchase or sale, bankruptcy, conveyance, lease, distribution arrangement, manufacturing arrangement

9


 
Non-Exclusive Patent License
(including any foundry arrangement), license, sublicense, option, other transfer or any other transaction of any type (any such transaction, an “ Acquisition ”), the sublicense grant set forth in Section 2.1 (or any sublicense thereunder granted pursuant to Section 2.2) shall not apply to such product(s) or technology or any improvements or derivatives thereto (even if such person or entity at some time after the applicable Acquisition is no longer an “Excluded Third Party” hereunder, whether pursuant to the provisos set forth in Section 1.7 or otherwise), and Palomar and its sublicensees shall retain any and all rights to enforce the Anderson Patents against Alma, Alma Affiliates, such Excluded Third Party or any other Third Party with respect to the same.
          (f) Prosecution . As between the Parties, Palomar shall have the sole right, but not the obligation, in its sole discretion (subject to the MGH Agreement) to prosecute, maintain, enforce and defend the Anderson Patents, and Alma and Alma Affiliates shall have no rights with respect to any such activities.
          (g) Other Transactions . Palomar may assign, convey, sell, lease, encumber, license, sublicense or otherwise transfer to or grant any right in or to (collectively, “ Transfer ”) a Third Party or Palomar Affiliate any and all of the Anderson Patents or the MGH Agreement, provided that any such transaction is made subject to the sublicense grant to Alma and Alma Affiliates set forth in Section 2.1 and shall not impose any additional obligations on Alma or Alma Affiliates.
          (h) Licensing Fees . Except as otherwise expressly provided herein, any amounts or other consideration owed by Palomar to any Third Party or Palomar Affiliate on account of the sublicense grant to Alma and Alma Affiliates set forth in Section 2.1 shall be the sole responsibility of Palomar.
     2.3. MGH Agreement . Palomar represents and warrants to Alma that the MGH Agreement, as redacted and attached hereto as Appendix B , is true and complete and in effect as of the Effective Date. In the event that the MGH Agreement is terminated for any reason before the expiration of all of the Valid Claims of the Anderson Patents, Alma and Alma Affiliates shall no longer have any further patent royalty obligations to Palomar under this Agreement from the date of such termination (other than for patent royalty obligations accrued hereunder before such date). Notwithstanding anything contained herein to the contrary, Palomar shall have no liability of any kind whatsoever as a result of any such termination.
     2.4. No Other Rights . Alma acknowledges and agrees that, as between the Parties, Palomar and MGH have all right, title and interest in and to the Anderson Patents, and that Alma and Alma Affiliates shall acquire no right, title or interest in or to the Anderson Patents, by implication, estoppel or otherwise, other than the sublicense grant to Alma and Alma Affiliates set forth in Section 2.1 or as otherwise expressly provided herein.
3. Other Obligations of Alma .
     3.1. Definitions for this Section 3 .
          (a) “ Exploit ” shall mean to make, have made, import, use, sell, or offer for sale, including to research, develop, register, modify, enhance, improve, Manufacture, have

10


 
Non-Exclusive Patent License
Manufactured, formulate, have used, export, transport, distribute, promote, market or have sold or otherwise dispose of.
          (b) “ Exploitation ” shall mean the making, having made, importation, use, sale, offering for sale or disposition of a product or process, including the research, development, registration, modification, enhancement, improvement, Manufacture, formulation, optimization, import, export, transport, distribution, promotion or marketing of a product or process.
          (c) “ Manufacture ” shall mean, with respect to a product or system, the manufacturing, processing, formulating, packaging, labeling, holding and quality control testing of such product or compound.
     3.2. Covenants.
          (a) For as long as the sublicense grant by Palomar to Alma and Alma Affiliates set forth in Section 2.1 is in effect (the “ Sublicense Term ”), Alma and Alma Affiliates shall not Exploit or otherwise practice the sublicenses to the Anderson Patents granted to Alma and Alma Affiliates by Palomar under Section 2.1 by:
               (i) developing any Licensed Products intended by Alma or any Alma Affiliates for use (in whole or in part) in the Consumer Field;
               (ii) marketing any Licensed Products in the Consumer Field; or
               (iii) developing or commercializing in or outside the Consumer Field any Female Accessory Product during its period of commercialization by Gillette or any Gillette licensee, provided that any apparatus, component, accessory, disposable or Consumable as to which Alma or any Alma Affiliate has expended material financial and other resources on its development or commercialization as a Light-Based Accessory Product before such Female Accessory Product is first commercialized by Gillette or any Gillette licensee shall not be subject to the restriction contained in this Section 3.2(a)(iii). All capitalized terms used in this Section 3.2(a)(iii), but not defined herein, shall have the meanings ascribed to them in the Gillette Agreement.
          (b) During the Sublicense Term, Alma and Alma Affiliates shall label Licensed Products commercialized outside the Consumer Field pursuant to the sublicense to the Anderson Patents granted to Alma and Alma Affiliates by Palomar under Section 2.1 with the following phrase (or similar words which fairly convey such products are for use only outside the Consumer Field): “not intended for consumer self-use.”
          (c) During the Sublicense Term, Alma and Alma Affiliates shall not, in the development and commercialization of Licensed Products outside the Consumer Field pursuant to the sublicense to the Anderson Patents granted to Alma and Alma Affiliates by Palomar under Section 2.1, intentionally (1) design, modify or otherwise improve any such Licensed Product(s) with the goal or intent of improving its efficacy or performance in the Consumer Field, or (2) optimize, induce, support or encourage the use of any such Licensed Products in the Consumer Field.

11


 
Non-Exclusive Patent License
          (d) The covenants of Alma and Alma Affiliates contained in Sections 3.2(a)(i), 3.2(a)(ii) and 3.2(c) shall not prevent Alma or any Alma Affiliates from conducting any activity, or exercising or granting any licenses or other rights, with respect to the practice of the Anderson Patents, that has as its goal or intent Exploitation of a product or system outside the Consumer Field and not Exploitation of a product or system in the Consumer Field, notwithstanding the possibility that such activity, exercise or grant may have applications in the Consumer Field.
          (e) All Consumer Field Users (as defined in Section 3.3(a)), other than Palomar, are hereby granted third-party beneficiary rights to enforce the provisions of this Section 3.2 provided that Palomar has granted such Consumer Field Users such rights in writing.
     3.3. Economic Adjustments for Off-Label Sales .
          (a) Alma and Alma Affiliates each agrees to make payments to (i) Gillette, (ii) any other Third Party to which Palomar has granted an exclusive sublicense under the Anderson Patents in a field that in whole or in part falls within the Consumer Field, and (iii) Palomar (collectively, “ Consumer Field Users ”), as appropriate, in the manner set forth below, to compensate any of them for certain lost profits, if any, resulting from net off-label purchases during the Sublicense Term of Licensed Products commercialized pursuant to the sublicense to the Anderson Patents granted to Alma and Alma Affiliates by Palomar under Section 2.1, for use in the Consumer Field.
          (b) In the event that a Consumer Field User shall suffer Lost Profits (calculated in the manner set forth in Section 3.3(c)) in excess of Five Million Dollars (U.S. $5,000,000) in any calendar year, then such Consumer Field User may submit a written notice to Alma or any Alma Affiliate (a “ Lost Profits Notice ”) specifying its aggregate Lost Profits for such calendar year and enclosing copies of (A) the Independent Study (as defined below) supporting such calculation and (B) this Agreement. Within one hundred and eighty (180) days after receipt thereof, Alma or the Alma Affiliate, as applicable, shall (1) remit payment to such Consumer Field User, to such bank account designated in the Lost Profits Notice, in an amount equal to the difference between such Lost Profits and Five Million Dollars (U.S. $5,000,000) or (2) provide to such Consumer Field User a detailed written critique of such calculation, propose a revised calculation of such Consumer Field User’s Lost Profits based on a new Independent Study, and enclose a copy of such Independent Study. In the event that Alma or such Alma Affiliate, as applicable, shall propose a revised calculation, Alma or such Alma Affiliate, as applicable, and such Consumer Field User shall meet within thirty (30) days thereafter to attempt in good faith to negotiate an agreed level of Lost Profits, or otherwise settle the dispute. In the event that Alma or such Alma Affiliate, as applicable, and such Consumer Field User shall fail to reach agreement at such meeting, either of them may bring a lawsuit in any court of competent jurisdiction to resolve such dispute.
          (c) The Lost Profits of such Consumer Field User for a calendar year during the Sublicense Term shall be determined as follows. Such Consumer Field User shall retain, at its expense, a nationally-recognized economic consulting firm to determine, for such year, on the basis of accepted accounting, market research, sampling and survey methodology, (A) the

12


 
Non-Exclusive Patent License
sales by Alma, Alma Affiliates, Alma Sublicensees and Alma’s agents for such year of Licensed Products, commercialized pursuant to the sublicense under the Anderson Patents granted to Alma and Alma Affiliates by Palomar under Section 2.1, that displaced sales by or on behalf of such Consumer Field User of products, intended for use in the Consumer Field, that use optical radiation for therapeutic or cosmetic effect, and (B) the sales of such products for such year by such Consumer Field User and its affiliates, sublicensees and agents that displaced sales of such Licensed Products by or on behalf of Alma or Alma Affiliates, (C) the average net profit of such Consumer Field User for each unit of product sold (on a country-by-country basis, as relevant), (D) the loss of sales resulting from net off-label sales, calculated on the basis of (A) and (B), and (E) the lost profits attributable to such net off-label sales, calculated on the basis of (C) and (D) (the “ Lost Profits ”). Such determinations shall be summarized and documented in a report prepared by such nationally-recognized economic consulting firm (the “ Independent Study ”).
          (d) All Consumer Field Users, other than Palomar, are hereby granted third-party beneficiary rights with respect to the provisions of this Section 3.3 provided that Palomar has granted such Consumer Field Users such rights in writing.
     3.4. Other Provisions .
          (a) The provisions of this Section 3 shall apply to Alma Sublicensees to the same extent as Alma and Alma Affiliates. The provisions of this Section 3 shall be in effect for only as long as the Sublicense Term, and further shall be in effect with respect to any particular Consumer Field User for only as long as such Consumer Field User has an exclusive sublicense under the Anderson Patents in a field that in whole or in part falls within the Consumer Field, provided that the end of the Sublicense Term shall not affect any obligations of Alma or Alma Affiliates under this Section 3 that have accrued as of the end of the Sublicense Term.
          (b) Palomar represents and warrants to Alma as of the Effective Date that the Gillette Agreement, excluding exhibits and redactions of other commercially sensitive information, and attached hereto as of the Effective Date as Appendix A , is true and complete and in effect as of the Effective Date.
4. Compensation .
     4.1. Flow-Chart . Attached hereto as Exhibit D are flow-charts showing how to determine royalty payments for the Sale of Licensed Products in accordance with the provisions of this Section 4. The Parties intend for those flow-charts and the provisions of this Section 4 to be read and construed as one document in order to understand the royalty obligations hereunder.
     4.2. Patent Royalties Arising from Past Sales.
          (a) Payment . Alma shall pay to Palomar within seven (7) days of the Effective Date Alma’s good faith estimate (which estimate for Sales of the Harmony System and Aria System to third party distributors outside the United States accruing before the Effective Date shall be made in accordance with the assumptions set forth in Section 4.2(d)) of the aggregate amount of royalties due pursuant to Section 4.4 for Sales of Licensed Products

13


 
Non-Exclusive Patent License
(except that the royalty rate applicable to Net Sales of such Licensed Products shall be nine and one half percent (9.5%) of such Net Sales) by Alma and Alma Affiliates accruing before the Effective Date, plus interest at the Applicable Rate (as defined in Section 4.2(b)). For clarity, such Sales shall include Sales of Licensed Products by predecessors in interest to Alma and Alma Affiliates, including MSQ, Ltd., Orion Lasers, Ltd. and Orion Lasers, Inc. The payment required by this Section 4.2 shall be made by wire transfer, without deduction for any taxes or other charges, as provided in Section 4.11. The payment required by this Section 4.2 is exclusive of any amounts payable by Alma to Palomar pursuant to the Settlement Agreement, including pursuant to Section 3(a) of the Settlement Agreement, or the that certain Trade Dress Settlement Agreement, to be executed contemporaneously with this Agreement, by and between Palomar and Alma (the “ TDS Agreement ”).
          (b) Interest . The payment set forth in Section 4.2(a) will include interest at the Applicable Rate calculated on a compound basis with a calendar quarterly compounding period from the date in the middle of the calendar quarter in which the Sale was made until the Effective Date. “Applicable Rate” shall mean a rate, starting from the first Sale of a Licensed Product until the payment date, published in The Wall Street Journal , Eastern United States Edition (“ WSJ ”) as the prime lending rate.
          (c) Audit . Such Sales of Licensed Products that give rise to the payment in Section 4.2(a) and applicable interest in Section 4.2(b) shall be auditable for a period of seven (7) years from the date of each such Sale as contemplated by Sections 4.9 and 4.10, and Alma shall be responsible for any under-payment of the amount owed Palomar under this Section 4.2 notwithstanding the terms of this Agreement, the Settlement Agreement or the TDS Agreement (including any release contained in the Settlement Agreement or TDS Agreement). The Parties acknowledge and agree that Alma shall be required to pay any initial under-payment under this Section 4.2 (the “ Initial Under-Payment ”) in full, plus interest at a rate equal to the rate of interest specified in Section 4.11 (calculated on a compound basis with a monthly compounding period from the date in the middle of the calendar quarter in which the Sale was made until the date payment is made, or if any portion of the Initial Under-Payment cannot reasonably be related to any such Sale so as to determine the start date for such interest calculation, then from January 1, 2006 for such portion), and not the Applicable Rate, and failure by Alma to pay the Initial Under-Payment, plus such interest, in full within forty-five (45) days following notice thereof shall constitute a material breach of this Agreement by Alma. For clarity, only one rate of interest shall apply to any Sale of Licensed Product, or any portion of Net Sales, not initially reported by Alma that gives rise to or results in the Initial Under-Payment, which rate of interest shall be equal to the rate of interest specified in Section 4.11 as determined above and not the Applicable Rate.
          (d) Estimate Assumptions . With respect to Alma’s good faith estimate of the royalties due pursuant to Section 4.4 for Sales of the Harmony System and Aria System by Alma and Alma Affiliates to third party distributors outside the United States accruing before the Effective Date only, the Parties acknowledge and agree that where accurate records are not available as to which Alma Hair Modules and Alma Other Modules were sold for use with particular base units/consoles by such distributors to end users the following assumptions are acceptable for purposes of determining such estimate:

14


 
Non-Exclusive Patent License
               (i) As of the Effective Date, the Alma Hair Modules and Alma Other Modules Sold for use with the Aria System base unit/console will also operate on the Harmony System base unit/console. Alma hereby represents that to the best of its knowledge the foregoing assumption is true.
               (ii) For purposes of Sections 4.2(d)(iii) and 4.2(d)(iv), any Alma Other Modules that can only operate on the Harmony System base unit/console shall only be included with and applied toward Sales of the Harmony System base unit/console.
               (iii) Since only one type of Alma Hair Module is Sold for use with the Harmony System and Aria System base units/consoles as of the Effective Date, where the number of Alma Hair Modules Sold to a distributor is less than or equal to the number of Harmony System and Aria System base units/consoles Sold to such distributor as of the Effective Date, it shall be assumed that no more than one Alma Hair Module was sold for use with any such particular base unit/console by the distributor to an end user (with priority given to the Harmony System base units/consoles). For example, if 9 Alma Hair Modules, 5 Harmony System base units/consoles and 5 Aria System base units/consoles are Sold to a distributor in the aggregate before the Effective Date, then (A) 1 Alma Hair Module would be deemed to have been Sold for use with each of the 5 Harmony System base units/consoles, and (B) 1 Alma Hair Module would be deemed to have been Sold for use with each of 4 of the Aria System base units/consoles. If the number of Alma Hair Modules Sold to a distributor is greater than the number of such base units/consoles Sold to such distributor as of the Effective Date, the number of Alma Hair Modules Sold to such distributor shall be spread evenly over the number of such base units/consoles Sold to such distributor (with priority given to the Harmony System base units/consoles). For example, if 12 Alma Hair Modules, 5 Harmony System base units/consoles and 5 Aria System base units/consoles are Sold to a distributor in the aggregate before the Effective Date, then (C) 1 Alma Hair Module would be deemed to have been Sold for use with each of the 5 Harmony System base units/consoles, (D) 1 additional Alma Hair Module would be deemed to have been Sold for use with each of 2 of the 5 Harmony System base units/consoles, and (E) 1 Alma Hair Module would be deemed to have been Sold for use with each of the 5 Aria System base units/consoles.
               (iv) For purposes of determining the number of Alma Other Modules sold for use with a Harmony System base unit/console or Aria System base unit/console Sold to a particular distributor, (i) the total number of Alma Other Modules Sold to a distributor that can be operated on both the Harmony System and Aria System base u

 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more